首页 > 最新文献

Annals of Surgical Treatment and Research最新文献

英文 中文
A single center experience on clinical outcome of fundoplication in pediatric patients: a retrospective cohort study. 一项回顾性队列研究:单中心经验对儿科患者鼻窦炎临床结果的影响。
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-03-01 Epub Date: 2025-02-28 DOI: 10.4174/astr.2025.108.3.177
Yuyoung Oh, Joong Kee Youn, Hee-Beom Yang, Hyun-Young Kim, Dayoung Ko

Purpose: The study aimed to evaluate the characteristics and operative-related factors in children who underwent fundoplication, analyze surgical outcomes categorized by disease entity and surgical indication, and identify prognostic factors for reoperation risk.

Methods: A total of 109 pediatric patients who underwent fundoplication between 2008 and 2022 were retrospectively analyzed. Patients were grouped by disease entity and surgical indication. Underlying diseases, comorbidities, sex, gestational age, birth weight, preoperative symptoms, and operation-related factors were examined. Outcomes were classified as short-term and long-term adverse events. We investigated differences in clinical outcomes according to disease entity and surgical indication. Then we statistically identified preoperative predictors for the risk of reoperation.

Results: The most common disease entity was neurological impairment (n = 92). Pulmonary comorbidity (42.2%) and aspiration/regurgitation (87.2%) were the most common. Most surgeries were performed laparoscopically (86.2%). There were 12 short-term and 25 long-term adverse events, with long-term events occurred more frequently in the neurological impairment (NIP) group compared to the non-NIP group (P = 0.04). None of the factors showed a significant relationship with the risk of reoperation.

Conclusion: Neurologically impaired children were more likely to experience long-term adverse events post-fundoplication. However, no significant predictors for reoperation risk were identified.

目的:本研究旨在评价儿童基底折叠手术的特点及手术相关因素,分析按疾病类型和手术指征分类的手术结果,并确定再手术风险的预后因素。方法:回顾性分析2008年至2022年间109例接受过子宫底翻手术的儿童患者。患者按疾病类型和手术指征分组。检查基础疾病、合并症、性别、胎龄、出生体重、术前症状和手术相关因素。结果分为短期和长期不良事件。我们根据疾病实体和手术指征调查临床结果的差异。然后,我们统计确定再手术风险的术前预测因素。结果:最常见的疾病实体为神经功能损害(n = 92)。肺部合并症(42.2%)和误吸/反流(87.2%)最为常见。腹腔镜下手术占86.2%。短期不良事件12例,长期不良事件25例,其中神经损伤(NIP)组长期不良事件发生率高于非NIP组(P = 0.04)。所有因素均未显示与再手术风险有显著关系。结论:神经功能受损的儿童更容易出现长期不良事件。然而,没有发现再手术风险的显著预测因素。
{"title":"A single center experience on clinical outcome of fundoplication in pediatric patients: a retrospective cohort study.","authors":"Yuyoung Oh, Joong Kee Youn, Hee-Beom Yang, Hyun-Young Kim, Dayoung Ko","doi":"10.4174/astr.2025.108.3.177","DOIUrl":"10.4174/astr.2025.108.3.177","url":null,"abstract":"<p><strong>Purpose: </strong>The study aimed to evaluate the characteristics and operative-related factors in children who underwent fundoplication, analyze surgical outcomes categorized by disease entity and surgical indication, and identify prognostic factors for reoperation risk.</p><p><strong>Methods: </strong>A total of 109 pediatric patients who underwent fundoplication between 2008 and 2022 were retrospectively analyzed. Patients were grouped by disease entity and surgical indication. Underlying diseases, comorbidities, sex, gestational age, birth weight, preoperative symptoms, and operation-related factors were examined. Outcomes were classified as short-term and long-term adverse events. We investigated differences in clinical outcomes according to disease entity and surgical indication. Then we statistically identified preoperative predictors for the risk of reoperation.</p><p><strong>Results: </strong>The most common disease entity was neurological impairment (n = 92). Pulmonary comorbidity (42.2%) and aspiration/regurgitation (87.2%) were the most common. Most surgeries were performed laparoscopically (86.2%). There were 12 short-term and 25 long-term adverse events, with long-term events occurred more frequently in the neurological impairment (NIP) group compared to the non-NIP group (P = 0.04). None of the factors showed a significant relationship with the risk of reoperation.</p><p><strong>Conclusion: </strong>Neurologically impaired children were more likely to experience long-term adverse events post-fundoplication. However, no significant predictors for reoperation risk were identified.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 3","pages":"177-185"},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11896763/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143622964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ulcerative colitis-associated colorectal neoplasm is increasing as a surgical indication in the biologics era: a retrospective observational study of 20 years of experience in a single tertiary center. 在生物制剂时代,溃疡性结肠炎相关的结直肠肿瘤作为手术指征正在增加:一项对单一三级中心20年经验的回顾性观察研究。
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-03-01 Epub Date: 2025-02-28 DOI: 10.4174/astr.2025.108.3.150
Hyo Jun Kim, Seung-Bum Ryoo, Jin Sun Choi, Han-Ki Lim, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park

Purpose: We aimed to identify changes in surgical indications in patients with ulcerative colitis (UC) in the biologics era in a single tertiary center.

Methods: In this retrospective observational study, 108 patients with UC who underwent abdominal surgery for UC at Seoul National University Hospital from 2000 to 2021 were included. We compared the total number of patients undergoing UC before and after the introduction of biologic therapy.

Results: Of the 108 patients with UC (male, 59 and female, 49; mean age, 46.8 years), 30 (27.8%) underwent surgery for neoplasms and 78 (72.2%) for medical intractability without neoplasms. The duration between diagnosis and surgery varied significantly (126.00 months vs. 60.50 months, P = 0.001). A significant difference was also noted in the surgical indications according to time (P = 0.02). Between 2000 and 2010, 12 patients (19.4%) underwent surgery for UC with neoplasms and 50 (80.6%) for UC without neoplasms, while between 2011 and 2021, 18 (39.1%) and 28 patients (60.9%) underwent surgery for UC with and without neoplasms, respectively.

Conclusion: Since 2011, when biological agents were covered by insurance in South Korea, there has been a relative increase in the incidence of surgical indications for neoplasia cases. Focusing on closely monitoring individuals with long-term UC for neoplasms is necessary.

目的:我们的目的是在单一三级中心确定生物制剂时代溃疡性结肠炎(UC)患者手术指征的变化。方法:在这项回顾性观察性研究中,纳入了2000年至2021年在首尔国立大学医院接受腹部手术治疗UC的108例UC患者。我们比较了引入生物治疗前后接受UC的患者总数。结果:108例UC患者(男59例,女49例;平均年龄46.8岁,因肿瘤手术30例(27.8%),无肿瘤手术78例(72.2%)。诊断和手术之间的时间差异显著(126.00个月vs 60.50个月,P = 0.001)。不同时间的手术指征差异有统计学意义(P = 0.02)。2000年至2010年,有肿瘤的UC手术12例(19.4%),无肿瘤的UC手术50例(80.6%),而2011年至2021年,有肿瘤的UC手术18例(39.1%),无肿瘤的UC手术28例(60.9%)。结论:自2011年韩国将生物制剂纳入保险范围以来,肿瘤病例的手术指征发生率相对增加。密切监测长期UC患者的肿瘤是必要的。
{"title":"Ulcerative colitis-associated colorectal neoplasm is increasing as a surgical indication in the biologics era: a retrospective observational study of 20 years of experience in a single tertiary center.","authors":"Hyo Jun Kim, Seung-Bum Ryoo, Jin Sun Choi, Han-Ki Lim, Min Jung Kim, Ji Won Park, Seung-Yong Jeong, Kyu Joo Park","doi":"10.4174/astr.2025.108.3.150","DOIUrl":"10.4174/astr.2025.108.3.150","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to identify changes in surgical indications in patients with ulcerative colitis (UC) in the biologics era in a single tertiary center.</p><p><strong>Methods: </strong>In this retrospective observational study, 108 patients with UC who underwent abdominal surgery for UC at Seoul National University Hospital from 2000 to 2021 were included. We compared the total number of patients undergoing UC before and after the introduction of biologic therapy.</p><p><strong>Results: </strong>Of the 108 patients with UC (male, 59 and female, 49; mean age, 46.8 years), 30 (27.8%) underwent surgery for neoplasms and 78 (72.2%) for medical intractability without neoplasms. The duration between diagnosis and surgery varied significantly (126.00 months <i>vs.</i> 60.50 months, P = 0.001). A significant difference was also noted in the surgical indications according to time (P = 0.02). Between 2000 and 2010, 12 patients (19.4%) underwent surgery for UC with neoplasms and 50 (80.6%) for UC without neoplasms, while between 2011 and 2021, 18 (39.1%) and 28 patients (60.9%) underwent surgery for UC with and without neoplasms, respectively.</p><p><strong>Conclusion: </strong>Since 2011, when biological agents were covered by insurance in South Korea, there has been a relative increase in the incidence of surgical indications for neoplasia cases. Focusing on closely monitoring individuals with long-term UC for neoplasms is necessary.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 3","pages":"150-157"},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11896760/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143623286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing recurrent laryngeal nerve localization during transoral endoscopic thyroid surgery using augmented reality: a proof-of-concept study. 利用增强现实技术加强经口内窥镜甲状腺手术中的喉返神经定位:概念验证研究。
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-03-01 Epub Date: 2025-02-28 DOI: 10.4174/astr.2025.108.3.135
Moon Young Oh, Yeonjin Choi, Taesoo Jang, Eun Kyung Choe, Hyoun-Joong Kong, Young Jun Chai

Purpose: During transoral endoscopic thyroidectomy, preserving the recurrent laryngeal nerve (RLN) is a major challenge because visualization of this nerve is often obstructed by the thyroid itself, increasing the risk of serious complications. This study explores the application of an augmented reality (AR) system to facilitate easier identification of the RLN during transoral endoscopic thyroidectomy.

Methods: Three patients scheduled for transoral endoscopic thyroidectomy were enrolled in this proof-of-concept study. Preoperative computed tomography scans were used to create an AR model that included the thyroid, trachea, veins, arteries, and RLN. The model was overlaid onto real-time endoscopic camera images during live surgeries. Manual registration of the AR model was performed using a customized controller. The model was aligned with surgical landmarks such as the trachea and common carotid artery. Manual registration accuracy was assessed using the Dice similarity coefficient (DSC) to evaluate the alignment between the real RLN and the RLN of the AR model.

Results: The 3 patients included were female (mean age, 33.3 ± 15.7 years), and the mean tumor size was 1.0 ± 0.3 cm. All patients underwent transoral endoscopic thyroidectomy of the right lobe. Final histopathological diagnoses comprised 2 papillary thyroid carcinomas and one follicular adenoma. The manual registration accuracy was 0.60, 0.70, and 0.57 for patients 1, 2, and 3, respectively, with a mean value of 0.6 ± 0.1.

Conclusion: The application of an AR system during transoral endoscopic thyroidectomy proved feasible and demonstrated potential for improving the localization of anatomical structures, particularly the RLN, as indicated by a moderate DSC.

目的:在经口内镜甲状腺切除术中,保留喉返神经(RLN)是一个主要的挑战,因为该神经的可视化经常被甲状腺本身阻塞,增加了严重并发症的风险。本研究探讨了增强现实(AR)系统在经口内镜甲状腺切除术中更容易识别RLN的应用。方法:三名计划经口内窥镜甲状腺切除术的患者加入了这项概念验证研究。术前计算机断层扫描用于创建AR模型,包括甲状腺、气管、静脉、动脉和RLN。该模型在实时手术过程中覆盖在实时内窥镜相机图像上。使用自定义控制器对AR模型进行手动配准。该模型与气管和颈总动脉等手术标志对齐。使用Dice相似系数(DSC)评估人工配准精度,以评估AR模型的真实RLN与RLN之间的对齐程度。结果:3例患者均为女性,平均年龄33.3±15.7岁,平均肿瘤大小1.0±0.3 cm。所有患者均行经口内窥镜右甲状腺切除术。最终病理诊断为2例乳头状甲状腺癌和1例滤泡腺瘤。患者1、2、3的人工配准精度分别为0.60、0.70、0.57,平均值为0.6±0.1。结论:经口内镜甲状腺切除术中应用AR系统被证明是可行的,并且显示出改善解剖结构定位的潜力,特别是RLN,如中等DSC所示。
{"title":"Enhancing recurrent laryngeal nerve localization during transoral endoscopic thyroid surgery using augmented reality: a proof-of-concept study.","authors":"Moon Young Oh, Yeonjin Choi, Taesoo Jang, Eun Kyung Choe, Hyoun-Joong Kong, Young Jun Chai","doi":"10.4174/astr.2025.108.3.135","DOIUrl":"10.4174/astr.2025.108.3.135","url":null,"abstract":"<p><strong>Purpose: </strong>During transoral endoscopic thyroidectomy, preserving the recurrent laryngeal nerve (RLN) is a major challenge because visualization of this nerve is often obstructed by the thyroid itself, increasing the risk of serious complications. This study explores the application of an augmented reality (AR) system to facilitate easier identification of the RLN during transoral endoscopic thyroidectomy.</p><p><strong>Methods: </strong>Three patients scheduled for transoral endoscopic thyroidectomy were enrolled in this proof-of-concept study. Preoperative computed tomography scans were used to create an AR model that included the thyroid, trachea, veins, arteries, and RLN. The model was overlaid onto real-time endoscopic camera images during live surgeries. Manual registration of the AR model was performed using a customized controller. The model was aligned with surgical landmarks such as the trachea and common carotid artery. Manual registration accuracy was assessed using the Dice similarity coefficient (DSC) to evaluate the alignment between the real RLN and the RLN of the AR model.</p><p><strong>Results: </strong>The 3 patients included were female (mean age, 33.3 ± 15.7 years), and the mean tumor size was 1.0 ± 0.3 cm. All patients underwent transoral endoscopic thyroidectomy of the right lobe. Final histopathological diagnoses comprised 2 papillary thyroid carcinomas and one follicular adenoma. The manual registration accuracy was 0.60, 0.70, and 0.57 for patients 1, 2, and 3, respectively, with a mean value of 0.6 ± 0.1.</p><p><strong>Conclusion: </strong>The application of an AR system during transoral endoscopic thyroidectomy proved feasible and demonstrated potential for improving the localization of anatomical structures, particularly the RLN, as indicated by a moderate DSC.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 3","pages":"135-142"},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11896764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143622966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomized controlled trial comparing liquid skin adhesives and staplers for surgical wound management. 一项比较液体皮肤粘接剂和吻合器用于外科伤口处理的随机对照试验。
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-03-01 Epub Date: 2025-02-28 DOI: 10.4174/astr.2025.108.3.143
Hyeon Woo Bae, Seung Yoon Yang, Ga Yoon Ku, Sohye Lee, Eun-Joo Jung, Seulkee Park, Yoon Bin Jung, Jihong Kim, Byung Soh Min

Purpose: Despite the widespread use of liquid skin adhesives (LSA), concerns persist regarding the increase in wound care costs. This study aimed to investigate the cost-effectiveness of LSA for surgical wound management.

Methods: In this prospective, open-label, single-center randomized controlled trial, adults aged 19 years and older who were scheduled for elective minimally invasive colorectal surgeries were included. The participants were randomly divided into 2 groups: an n-butyl cyanoacrylate skin adhesive was used in the experimental group (LSA group), while a surgical skin stapler was employed in the control group (stapler group). The primary outcome measure was the sum of the total time required for wound management.

Results: A total of 58 patients were randomly assigned to 2 groups, with 29 patients in each group. The findings revealed comparable wound complication rates in the 2 groups (8 out of 29 in the LSA group vs. 5 out of 29 in the stapler group, P = 0.530). Notably, the LSA group had a significantly shorter wound management time (median 235 seconds vs. 1,201 seconds, P < 0.001) and similar wound management cost (median US dollar [USD] 50.6 vs. USD 54.6, P = 0.529) compared to the stapler group. Subgroup analysis showed that the LSA group had a shorter management time for uncomplicated wounds and a lower cost for complicated wounds.

Conclusion: LSA not only provides a safe alternative but also offers a resource-efficient option for wound management compared to staplers.

目的:尽管液体皮肤粘接剂(LSA)的广泛使用,但对伤口护理费用增加的担忧仍然存在。本研究旨在探讨LSA在外科伤口处理中的成本-效果。方法:在这项前瞻性、开放标签、单中心随机对照试验中,纳入了19岁及以上计划进行选择性微创结直肠手术的成年人。随机分为两组:实验组采用氰基丙烯酸酯正丁酯皮肤胶粘剂(LSA组),对照组采用外科皮肤吻合器(吻合器组)。主要结局指标是伤口处理所需总时间的总和。结果:58例患者随机分为2组,每组29例。结果显示两组的伤口并发症发生率相当(LSA组29例中有8例,吻合器组29例中有5例,P = 0.530)。值得注意的是,与订书机组相比,LSA组的伤口管理时间明显更短(中位235秒vs. 1201秒,P < 0.001),伤口管理成本相似(中位美元[USD] 50.6 vs. 54.6美元,P = 0.529)。亚组分析显示,LSA组对非复杂伤口的治疗时间较短,对复杂伤口的治疗费用较低。结论:与吻合器相比,LSA不仅提供了一种安全的选择,而且提供了一种资源有效的伤口管理选择。
{"title":"A randomized controlled trial comparing liquid skin adhesives and staplers for surgical wound management.","authors":"Hyeon Woo Bae, Seung Yoon Yang, Ga Yoon Ku, Sohye Lee, Eun-Joo Jung, Seulkee Park, Yoon Bin Jung, Jihong Kim, Byung Soh Min","doi":"10.4174/astr.2025.108.3.143","DOIUrl":"10.4174/astr.2025.108.3.143","url":null,"abstract":"<p><strong>Purpose: </strong>Despite the widespread use of liquid skin adhesives (LSA), concerns persist regarding the increase in wound care costs. This study aimed to investigate the cost-effectiveness of LSA for surgical wound management.</p><p><strong>Methods: </strong>In this prospective, open-label, single-center randomized controlled trial, adults aged 19 years and older who were scheduled for elective minimally invasive colorectal surgeries were included. The participants were randomly divided into 2 groups: an n-butyl cyanoacrylate skin adhesive was used in the experimental group (LSA group), while a surgical skin stapler was employed in the control group (stapler group). The primary outcome measure was the sum of the total time required for wound management.</p><p><strong>Results: </strong>A total of 58 patients were randomly assigned to 2 groups, with 29 patients in each group. The findings revealed comparable wound complication rates in the 2 groups (8 out of 29 in the LSA group <i>vs.</i> 5 out of 29 in the stapler group, P = 0.530). Notably, the LSA group had a significantly shorter wound management time (median 235 seconds <i>vs.</i> 1,201 seconds, P < 0.001) and similar wound management cost (median US dollar [USD] 50.6 <i>vs.</i> USD 54.6, P = 0.529) compared to the stapler group. Subgroup analysis showed that the LSA group had a shorter management time for uncomplicated wounds and a lower cost for complicated wounds.</p><p><strong>Conclusion: </strong>LSA not only provides a safe alternative but also offers a resource-efficient option for wound management compared to staplers.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 3","pages":"143-149"},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11896759/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143622963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scaffold implantation vs. intravenous delivery: a comparative preclinical animal study evaluating peroxisome proliferator-activated receptor gamma coactivator 1-alpha adipose-derived stem cells in liver fibrosis treatment. 支架植入与静脉输送:一项评估过氧化物酶体增殖体激活受体γ辅助激活因子1- α脂肪来源干细胞在肝纤维化治疗中的临床前动物研究。
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-03-01 Epub Date: 2025-02-28 DOI: 10.4174/astr.2025.108.3.186
Joseph Ahn, Jung Hyun Park, Ho Joong Choi, Dosang Lee, Ha-Eun Hong, Ok-Hee Kim, Say-June Kim

Purpose: Regenerative medicine is expected to offer an alternative to liver transplantation for treating liver diseases in the future, with one significant challenge being the establishment of an effective stem cell administration route. This study assessed the antifibrogenic effects of adipose-derived stem cells (ASCs) in a liver fibrosis mouse model, focusing on 2 methods of delivery: intravenous injection and scaffold implantation.

Methods: An extracellular matrix mimic scaffold was utilized for culturing peroxisome proliferator-activated receptor gamma coactivator 1-alpha-overexpressing ASCs (tASCs). These scaffolds, laden with tASCs, were then implanted subcutaneously in mice exhibiting liver fibrosis. In contrast, the Cell groups received biweekly intravenous injections of tASCs for 4 weeks. After 4 weeks, tissue samples were harvested from the euthanized mice for subsequent analysis.

Results: Real-time PCR and Western blot analyses on liver tissues, focusing on markers like alpha-smooth muscle actin (α-SMA), matrix metalloproteinase-2, and transforming growth factor-beta 1 (TGF-β1), showed that both delivery routes substantially lowered fibrotic and inflammatory markers compared to controls (P < 0.05), with no significant differences between the routes. Histological examinations, along with immunohistochemical analysis of α-SMA, collagen type I alpha, and TGF-β1, revealed that the scaffold implantation approach resulted in a greater reduction in fibrosis and lower immunoreactivity for fibrotic markers than intravenous delivery (P < 0.05).

Conclusion: These findings indicate that delivering tASCs via a scaffold could be more effective, or at least similarly effective, in treating liver fibrosis compared to intravenous delivery. Scaffold implantation could offer a beneficial alternative to frequent intravenous treatments, suggesting its potential utility in clinical applications for liver disease treatment.

目的:再生医学有望在未来为治疗肝脏疾病提供肝脏移植手术的替代方案,其中一个重大挑战是建立有效的干细胞给药途径。本研究评估了脂肪源性干细胞(ASCs)在肝纤维化小鼠模型中的抗纤维化作用,重点关注两种给药方法:静脉注射和支架植入:方法:利用细胞外基质模拟支架培养过氧化物酶体增殖体激活受体γ辅助激活剂1-α过表达ASCs(tASCs)。然后将这些富含 tASCs 的支架皮下植入出现肝纤维化的小鼠体内。相比之下,细胞组则每两周接受一次 tASCs 静脉注射,持续 4 周。4 周后,从安乐死的小鼠身上采集组织样本进行后续分析:肝组织的实时 PCR 和 Western 印迹分析表明,与对照组相比,两种给药途径都能显著降低纤维化和炎症指标(P < 0.05),且不同给药途径之间无显著差异。组织学检查以及对α-SMA、Ⅰ型胶原α和TGF-β1的免疫组化分析表明,与静脉注射相比,支架植入法能更大程度地减少纤维化,降低纤维化标志物的免疫活性(P<0.05):这些研究结果表明,与静脉注射相比,通过支架输送 tASCs 治疗肝纤维化可能更有效,或至少具有类似效果。支架植入可以替代频繁的静脉注射治疗,这表明支架植入在肝病治疗的临床应用中具有潜在的实用性。
{"title":"Scaffold implantation <i>vs.</i> intravenous delivery: a comparative preclinical animal study evaluating peroxisome proliferator-activated receptor gamma coactivator 1-alpha adipose-derived stem cells in liver fibrosis treatment.","authors":"Joseph Ahn, Jung Hyun Park, Ho Joong Choi, Dosang Lee, Ha-Eun Hong, Ok-Hee Kim, Say-June Kim","doi":"10.4174/astr.2025.108.3.186","DOIUrl":"10.4174/astr.2025.108.3.186","url":null,"abstract":"<p><strong>Purpose: </strong>Regenerative medicine is expected to offer an alternative to liver transplantation for treating liver diseases in the future, with one significant challenge being the establishment of an effective stem cell administration route. This study assessed the antifibrogenic effects of adipose-derived stem cells (ASCs) in a liver fibrosis mouse model, focusing on 2 methods of delivery: intravenous injection and scaffold implantation.</p><p><strong>Methods: </strong>An extracellular matrix mimic scaffold was utilized for culturing peroxisome proliferator-activated receptor gamma coactivator 1-alpha-overexpressing ASCs (tASCs). These scaffolds, laden with tASCs, were then implanted subcutaneously in mice exhibiting liver fibrosis. In contrast, the Cell groups received biweekly intravenous injections of tASCs for 4 weeks. After 4 weeks, tissue samples were harvested from the euthanized mice for subsequent analysis.</p><p><strong>Results: </strong>Real-time PCR and Western blot analyses on liver tissues, focusing on markers like alpha-smooth muscle actin (α-SMA), matrix metalloproteinase-2, and transforming growth factor-beta 1 (TGF-β1), showed that both delivery routes substantially lowered fibrotic and inflammatory markers compared to controls (P < 0.05), with no significant differences between the routes. Histological examinations, along with immunohistochemical analysis of α-SMA, collagen type I alpha, and TGF-β1, revealed that the scaffold implantation approach resulted in a greater reduction in fibrosis and lower immunoreactivity for fibrotic markers than intravenous delivery (P < 0.05).</p><p><strong>Conclusion: </strong>These findings indicate that delivering tASCs via a scaffold could be more effective, or at least similarly effective, in treating liver fibrosis compared to intravenous delivery. Scaffold implantation could offer a beneficial alternative to frequent intravenous treatments, suggesting its potential utility in clinical applications for liver disease treatment.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 3","pages":"186-197"},"PeriodicalIF":1.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11896761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143623256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The safety and anti-adhesive effect of acellular dermal matrix application after thyroid surgery: a multicenter randomized controlled trial. 甲状腺手术后应用脱细胞真皮基质的安全性和抗粘附效果:一项多中心随机对照试验。
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-02-01 Epub Date: 2025-01-24 DOI: 10.4174/astr.2025.108.2.71
Kwangsoon Kim, Young Jun Chai, Mira Han, Sang-Wook Kang, Ji-Sup Yun

Purpose: Postoperative adhesions following thyroid surgery can lead to multiple complications that significantly impact quality of life. The use of an acellular dermal matrix (ADM) adhesion barrier device has been proposed as a potential solution to reduce the risk of such adhesions. This study aimed to evaluate the safety and anti-adhesive effect of an ADM in patients undergoing thyroid surgery.

Methods: In this multicenter randomized controlled trial, patients undergoing thyroid surgery were randomly assigned to receive either ADM (n = 42) or no ADM (n = 39) during surgery. The primary outcome was the Swallowing Impairment Score (SIS-6), measured 6 weeks after surgery and compared between groups. Secondary outcomes included intergroup comparisons of the SIS-6, the Voice Handicap Index (VHI)-10, and the Glasgow-Edinburgh Throat Scale (GETS) at baseline, and 2, 6, and 18 weeks after surgery.

Results: At week 6, the mean SIS-6 scores were 4.0 ± 4.1 and 3.3 ± 4.2 in the ADM and control groups, respectively, which was not significantly different. Both groups showed similar postoperative improvements in SIS-6, VHI-10, and GETS scores over time, without significant differences between groups at any time point, indicating that the ADM did not reduce the incidence of postoperative adhesions or alter the course of recovery compared to the control group.

Conclusion: Although application of the ADM is safe for use in patients undergoing thyroid surgery, it did not produce a clinically significant advantage in preventing postoperative adhesions. Future research should focus on identifying specific patient populations or surgical scenarios where the use of the ADM may be beneficial.

目的:甲状腺手术后粘连可导致多种并发症,严重影响生活质量。脱细胞真皮基质(ADM)粘连屏障装置的使用被认为是减少这种粘连风险的潜在解决方案。本研究旨在评价一种ADM在甲状腺手术患者中的安全性和抗粘连效果。方法:在这项多中心随机对照试验中,接受甲状腺手术的患者被随机分配到手术期间接受ADM (n = 42)和不接受ADM (n = 39)。主要终点是术后6周的吞咽障碍评分(SIS-6),并在两组之间进行比较。次要结果包括组间比较SIS-6、语音障碍指数(VHI)-10和格拉斯哥-爱丁堡喉咙量表(GETS)在基线、术后2周、6周和18周。结果:在第6周,ADM组和对照组的SIS-6平均评分分别为4.0±4.1和3.3±4.2,差异无统计学意义。两组术后SIS-6、VHI-10和GETS评分随时间的改善情况相似,各组之间在任何时间点均无显著差异,表明与对照组相比,ADM没有减少术后粘连的发生率或改变恢复过程。结论:虽然在甲状腺手术患者中应用ADM是安全的,但在预防术后粘连方面没有明显的临床优势。未来的研究应侧重于确定使用ADM可能有益的特定患者群体或手术场景。
{"title":"The safety and anti-adhesive effect of acellular dermal matrix application after thyroid surgery: a multicenter randomized controlled trial.","authors":"Kwangsoon Kim, Young Jun Chai, Mira Han, Sang-Wook Kang, Ji-Sup Yun","doi":"10.4174/astr.2025.108.2.71","DOIUrl":"10.4174/astr.2025.108.2.71","url":null,"abstract":"<p><strong>Purpose: </strong>Postoperative adhesions following thyroid surgery can lead to multiple complications that significantly impact quality of life. The use of an acellular dermal matrix (ADM) adhesion barrier device has been proposed as a potential solution to reduce the risk of such adhesions. This study aimed to evaluate the safety and anti-adhesive effect of an ADM in patients undergoing thyroid surgery.</p><p><strong>Methods: </strong>In this multicenter randomized controlled trial, patients undergoing thyroid surgery were randomly assigned to receive either ADM (n = 42) or no ADM (n = 39) during surgery. The primary outcome was the Swallowing Impairment Score (SIS-6), measured 6 weeks after surgery and compared between groups. Secondary outcomes included intergroup comparisons of the SIS-6, the Voice Handicap Index (VHI)-10, and the Glasgow-Edinburgh Throat Scale (GETS) at baseline, and 2, 6, and 18 weeks after surgery.</p><p><strong>Results: </strong>At week 6, the mean SIS-6 scores were 4.0 ± 4.1 and 3.3 ± 4.2 in the ADM and control groups, respectively, which was not significantly different. Both groups showed similar postoperative improvements in SIS-6, VHI-10, and GETS scores over time, without significant differences between groups at any time point, indicating that the ADM did not reduce the incidence of postoperative adhesions or alter the course of recovery compared to the control group.</p><p><strong>Conclusion: </strong>Although application of the ADM is safe for use in patients undergoing thyroid surgery, it did not produce a clinically significant advantage in preventing postoperative adhesions. Future research should focus on identifying specific patient populations or surgical scenarios where the use of the ADM may be beneficial.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 2","pages":"71-78"},"PeriodicalIF":1.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813551/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143405504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The power of platelet-rich plasma on operated pilonidal disease: a prospective randomized controlled trial. 富血小板血浆对手术后毛鞘疾病的作用:一项前瞻性随机对照试验
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-02-01 Epub Date: 2025-01-24 DOI: 10.4174/astr.2025.108.2.124
Bourak Chousein, Engin Olcucuoglu, Ismail Oskay Kaya

Purpose: Pilonidal sinus disease is a chronic inflammatory disease that affects approximately 1% of the population. Although many treatment methods have been described, there is no consensus on the exact treatment method. This study was conducted to evaluate the wound healing-promoting effect of platelet-rich plasma (PRP) in patients treated using the unroofing and curettage technique.

Methods: A total of 140 patients diagnosed with pilonidal sinus disease were included in the study. The patients were randomized into 2 groups; one group was followed up with a standard dressing after the operation, and the patients in the other group were treated with PRP in addition to the standard dressing. In this study, the wound healing rate between the 2 groups was determined as the primary objective.

Results: In postoperative follow-up, a difference in wound healing rate was detected on postoperative day 10 (P = 0.007). While the average wound healing time of the patients in the control group was 41.1 ± 11.0 days (median, 40; range, 20-65), it was 23.6 ± 8.5 days (median, 25; range, 6-45) in the PRP group (P < 0.001). It was determined that the wound closure time of patients in the PRP group was faster.

Conclusion: In our prospective randomized study, we found that PRP significantly increased the wound healing rate and patient comfort, with recurrence rates below 1% and minimal pain. We think that it should be the first-choice method before operations that cause extensive tissue loss, such as flap surgery.

目的:毛窦疾病是一种影响约1%人口的慢性炎症性疾病。虽然许多治疗方法已经被描述,但对于确切的治疗方法尚无共识。本研究旨在探讨富血小板血浆(PRP)对开颅刮刮术患者创面愈合的促进作用。方法:共纳入140例诊断为毛突窦疾病的患者。患者随机分为两组;一组术后随访标准敷料,另一组在标准敷料的基础上加用PRP。本研究以两组间创面愈合率为主要目的。结果:术后随访,术后第10天创面愈合率差异有统计学意义(P = 0.007)。对照组患者伤口愈合时间平均为41.1±11.0天(中位数40;范围:20-65),为23.6±8.5天(中位数:25;范围,6-45)(P < 0.001)。结果表明,PRP组患者的伤口愈合时间更快。结论:在我们的前瞻性随机研究中,我们发现PRP显著提高了伤口愈合率和患者舒适度,复发率低于1%,疼痛最小。我们认为它应该是手术前的首选方法,造成广泛的组织损失,如皮瓣手术。
{"title":"The power of platelet-rich plasma on operated pilonidal disease: a prospective randomized controlled trial.","authors":"Bourak Chousein, Engin Olcucuoglu, Ismail Oskay Kaya","doi":"10.4174/astr.2025.108.2.124","DOIUrl":"10.4174/astr.2025.108.2.124","url":null,"abstract":"<p><strong>Purpose: </strong>Pilonidal sinus disease is a chronic inflammatory disease that affects approximately 1% of the population. Although many treatment methods have been described, there is no consensus on the exact treatment method. This study was conducted to evaluate the wound healing-promoting effect of platelet-rich plasma (PRP) in patients treated using the unroofing and curettage technique.</p><p><strong>Methods: </strong>A total of 140 patients diagnosed with pilonidal sinus disease were included in the study. The patients were randomized into 2 groups; one group was followed up with a standard dressing after the operation, and the patients in the other group were treated with PRP in addition to the standard dressing. In this study, the wound healing rate between the 2 groups was determined as the primary objective.</p><p><strong>Results: </strong>In postoperative follow-up, a difference in wound healing rate was detected on postoperative day 10 (P = 0.007). While the average wound healing time of the patients in the control group was 41.1 ± 11.0 days (median, 40; range, 20-65), it was 23.6 ± 8.5 days (median, 25; range, 6-45) in the PRP group (P < 0.001). It was determined that the wound closure time of patients in the PRP group was faster.</p><p><strong>Conclusion: </strong>In our prospective randomized study, we found that PRP significantly increased the wound healing rate and patient comfort, with recurrence rates below 1% and minimal pain. We think that it should be the first-choice method before operations that cause extensive tissue loss, such as flap surgery.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 2","pages":"124-134"},"PeriodicalIF":1.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143405501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic anticancer effects of mitochondria-targeting peptide combined with paclitaxel in breast cancer cells: a preclinical study. 线粒体靶向肽联合紫杉醇对乳腺癌细胞的协同抗癌作用:临床前研究
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-02-01 Epub Date: 2025-01-24 DOI: 10.4174/astr.2025.108.2.108
Juneyoung Ahn, Ok-Hee Kim, Seongeon Jin, Ja-Hyoung Ryu, Dosang Lee, Woo-Chan Park, Say-June Kim

Purpose: Mitochondria-accumulating amphiphilic peptide (Mito-FF) was designed to selectively target mitochondria in cancer cells and enhance anticancer effects through its unique structure. Mito-FF consists of (1) diphenylalanine, a β-sheet-forming building block critical for self-assembly; (2) triphenylphosphonium, a mitochondrial targeting moiety guiding the peptide to mitochondria; and (3) pyrene, a fluorescent probe enabling visualization of its accumulation and self-assembly. This study evaluates the anticancer efficacy of Mito-FF in breast cancer cells and explores its combination with paclitaxel, a standard therapy for breast cancer, focusing on its modulation of the epithelial-mesenchymal transition (EMT) pathway.

Methods: In vitro and in vivo experiments were performed using MCF-7 and MDA-MB-231 breast cancer cell lines and their respective xenograft models. Cell viability, migration, EMT marker expression, and apoptosis-related proteins were analyzed.

Results: Mito-FF demonstrated superior inhibition of cell viability and migration compared to paclitaxel alone in both cell lines. Combination therapy with Mito-FF and paclitaxel resulted in enhanced reduction of cell viability and migration. EMT markers were significantly modulated, with decreased mesenchymal markers (Snail and vimentin) and increased epithelial marker (E-cadherin) following combination treatment. Furthermore, the combination therapy synergistically elevated pro-apoptotic markers such as poly (adenosine diphosphate-ribose) polymerase and reduced anti-apoptotic markers such as myeloid cell leukemia 1. In vivo experiments revealed a marked reduction in tumor volume with combination therapy, accompanied by the highest expression levels of E-cadherin and pro-apoptotic marker Bim.

Conclusion: Mito-FF, designed for mitochondrial targeting and visualization, exhibited potent anticancer effects when combined with paclitaxel, in the breast cancer cells.

目的:设计线粒体积累两亲肽(Mito-FF),通过其独特的结构选择性靶向癌细胞内的线粒体,增强其抗癌作用。Mito-FF由(1)二苯丙氨酸组成,二苯丙氨酸是一种对自组装至关重要的β-薄片形成构件;(2) triphenylphosphonium,一个线粒体靶向片段,引导肽到达线粒体;(3)芘,一种荧光探针,可以可视化其积累和自组装。本研究评估Mito-FF对乳腺癌细胞的抗癌作用,并探讨其与乳腺癌标准治疗紫杉醇的联用,重点研究其对上皮-间质转化(EMT)通路的调节作用。方法:采用MCF-7和MDA-MB-231乳腺癌细胞株及其异种移植模型进行体外和体内实验。分析细胞活力、迁移、EMT标志物表达和凋亡相关蛋白。结果:在两种细胞系中,与紫杉醇单独相比,Mito-FF表现出更好的细胞活力和迁移抑制作用。Mito-FF和紫杉醇联合治疗可增强细胞活力和迁移的减少。EMT标记显著调节,联合治疗后间充质标记(Snail和vimentin)减少,上皮标记(E-cadherin)增加。此外,联合治疗可协同提高促凋亡标志物,如聚二磷酸腺苷核糖聚合酶,并降低抗凋亡标志物,如髓细胞白血病1。体内实验显示,联合治疗可显著减少肿瘤体积,同时E-cadherin和促凋亡标志物Bim的表达水平最高。结论:为线粒体靶向和可视化设计的Mito-FF与紫杉醇联合使用时,在乳腺癌细胞中表现出强大的抗癌作用。
{"title":"Synergistic anticancer effects of mitochondria-targeting peptide combined with paclitaxel in breast cancer cells: a preclinical study.","authors":"Juneyoung Ahn, Ok-Hee Kim, Seongeon Jin, Ja-Hyoung Ryu, Dosang Lee, Woo-Chan Park, Say-June Kim","doi":"10.4174/astr.2025.108.2.108","DOIUrl":"10.4174/astr.2025.108.2.108","url":null,"abstract":"<p><strong>Purpose: </strong>Mitochondria-accumulating amphiphilic peptide (Mito-FF) was designed to selectively target mitochondria in cancer cells and enhance anticancer effects through its unique structure. Mito-FF consists of (1) diphenylalanine, a β-sheet-forming building block critical for self-assembly; (2) triphenylphosphonium, a mitochondrial targeting moiety guiding the peptide to mitochondria; and (3) pyrene, a fluorescent probe enabling visualization of its accumulation and self-assembly. This study evaluates the anticancer efficacy of Mito-FF in breast cancer cells and explores its combination with paclitaxel, a standard therapy for breast cancer, focusing on its modulation of the epithelial-mesenchymal transition (EMT) pathway.</p><p><strong>Methods: </strong><i>In vitro</i> and <i>in vivo</i> experiments were performed using MCF-7 and MDA-MB-231 breast cancer cell lines and their respective xenograft models. Cell viability, migration, EMT marker expression, and apoptosis-related proteins were analyzed.</p><p><strong>Results: </strong>Mito-FF demonstrated superior inhibition of cell viability and migration compared to paclitaxel alone in both cell lines. Combination therapy with Mito-FF and paclitaxel resulted in enhanced reduction of cell viability and migration. EMT markers were significantly modulated, with decreased mesenchymal markers (Snail and vimentin) and increased epithelial marker (E-cadherin) following combination treatment. Furthermore, the combination therapy synergistically elevated pro-apoptotic markers such as poly (adenosine diphosphate-ribose) polymerase and reduced anti-apoptotic markers such as myeloid cell leukemia 1. <i>In vivo</i> experiments revealed a marked reduction in tumor volume with combination therapy, accompanied by the highest expression levels of E-cadherin and pro-apoptotic marker Bim.</p><p><strong>Conclusion: </strong>Mito-FF, designed for mitochondrial targeting and visualization, exhibited potent anticancer effects when combined with paclitaxel, in the breast cancer cells.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 2","pages":"108-123"},"PeriodicalIF":1.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143405497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can proximal gastrectomy be an alternative to total gastrectomy due to its nutritional advantage? A retrospective cohort study. 近端胃切除术是否可以替代全胃切除术,因为其营养优势?回顾性队列研究。
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-02-01 Epub Date: 2025-01-24 DOI: 10.4174/astr.2025.108.2.79
Ogün Aydoğan, Muhammed Çağrı Coşkun, Ulaş Utku Şekerci, Erdem Barış Cartı

Purpose: This study aims to evaluate the outcomes of proximal gastrectomy (PG) compared to total gastrectomy (TG) in patients with proximal stomach cancer, focusing on nutritional advantages and overall survival.

Methods: A retrospective review was conducted on 87 patients who underwent gastrectomy for stomach cancer at Adnan Menderes University from January 2016 to January 2023. Among them, 21 patients underwent PG and 32 patients underwent TG. Clinical parameters, nutritional status, postoperative gastrointestinal symptoms, and survival rates were compared between the 2 groups. Statistical analyses included the chi-square test, Student t-test, and Mann-Whitney U-test.

Results: The PG group showed significantly less weight loss at 12 months (6.9 ± 5.2 kg vs. 17.9 ± 4.0 kg, P < 0.001) and higher albumin levels at both 6 and 12 months, postoperatively (P < 0.001). The reflux index was higher in the PG group (9.4 ± 2.4 vs. 5.2 ± 1.6, P < 0.001), but there was no significant difference in overall Gastrointestinal Symptom Rating Scale scores (P = 0.266). Disease-specific and overall survival were significantly better in the PG group (P = 0.004 and P = 0.003, respectively).

Conclusion: PG offers significant nutritional advantages and improved survival outcomes compared to TG despite higher rates of reflux. These findings suggest that PG can be a viable, function-preserving alternative to TG for patients with proximal stomach cancer. Further large-scale, prospective studies are needed to confirm these results and ensure oncological safety.

目的:本研究旨在评估近端胃癌患者行近端胃切除术(PG)与全胃切除术(TG)的预后,重点关注营养优势和总生存期。方法:回顾性分析2016年1月至2023年1月Adnan Menderes大学87例胃癌切除术患者的资料。其中PG 21例,TG 32例。比较两组患者的临床参数、营养状况、术后胃肠道症状及生存率。统计分析包括卡方检验、学生t检验和Mann-Whitney u检验。结果:PG组术后12个月体重减轻(6.9±5.2 kg vs. 17.9±4.0 kg, P < 0.001),术后6个月和12个月白蛋白水平均升高(P < 0.001)。PG组反流指数较高(9.4±2.4比5.2±1.6,P < 0.001),但胃肠道症状评定量表总分无显著差异(P = 0.266)。PG组的疾病特异性和总生存率显著高于对照组(P = 0.004和P = 0.003)。结论:尽管反流率较高,但与TG相比,PG具有显著的营养优势和改善的生存结果。这些发现表明PG可以作为近端胃癌患者的一种可行的、保留功能的替代TG。需要进一步的大规模前瞻性研究来证实这些结果并确保肿瘤安全性。
{"title":"Can proximal gastrectomy be an alternative to total gastrectomy due to its nutritional advantage? A retrospective cohort study.","authors":"Ogün Aydoğan, Muhammed Çağrı Coşkun, Ulaş Utku Şekerci, Erdem Barış Cartı","doi":"10.4174/astr.2025.108.2.79","DOIUrl":"10.4174/astr.2025.108.2.79","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to evaluate the outcomes of proximal gastrectomy (PG) compared to total gastrectomy (TG) in patients with proximal stomach cancer, focusing on nutritional advantages and overall survival.</p><p><strong>Methods: </strong>A retrospective review was conducted on 87 patients who underwent gastrectomy for stomach cancer at Adnan Menderes University from January 2016 to January 2023. Among them, 21 patients underwent PG and 32 patients underwent TG. Clinical parameters, nutritional status, postoperative gastrointestinal symptoms, and survival rates were compared between the 2 groups. Statistical analyses included the chi-square test, Student t-test, and Mann-Whitney U-test.</p><p><strong>Results: </strong>The PG group showed significantly less weight loss at 12 months (6.9 ± 5.2 kg <i>vs.</i> 17.9 ± 4.0 kg, P < 0.001) and higher albumin levels at both 6 and 12 months, postoperatively (P < 0.001). The reflux index was higher in the PG group (9.4 ± 2.4 <i>vs.</i> 5.2 ± 1.6, P < 0.001), but there was no significant difference in overall Gastrointestinal Symptom Rating Scale scores (P = 0.266). Disease-specific and overall survival were significantly better in the PG group (P = 0.004 and P = 0.003, respectively).</p><p><strong>Conclusion: </strong>PG offers significant nutritional advantages and improved survival outcomes compared to TG despite higher rates of reflux. These findings suggest that PG can be a viable, function-preserving alternative to TG for patients with proximal stomach cancer. Further large-scale, prospective studies are needed to confirm these results and ensure oncological safety.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 2","pages":"79-85"},"PeriodicalIF":1.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143405433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced recovery after laparoscopic distal gastrectomy using articulating laparoscopic instruments in older adults with gastric cancer: a retrospective analysis of prospectively collected data. 使用关节式腹腔镜器械对老年胃癌患者进行腹腔镜远端胃切除术后的恢复:前瞻性收集数据的回顾性分析
IF 1.2 4区 医学 Q3 SURGERY Pub Date : 2025-02-01 Epub Date: 2025-01-24 DOI: 10.4174/astr.2025.108.2.86
Seohee Choi, Takahiro Kinoshita, Kazutaka Obama, Katsunobu Sakurai, Naoshi Kubo, Naruhiko Ikoma, Ali Guner, Hyoung-Il Kim

Purpose: As the number of older adults with gastric cancer requiring gastrectomy has increased, it has become increasingly important to use techniques that enhance surgical safety and reduce postoperative complications in this vulnerable patient population. Articulating laparoscopic instruments (ALIs) may improve maneuverability and precision, leading to better outcomes in older patients. This study aimed to compare postoperative outcomes of older adults undergoing laparoscopic distal gastrectomy for gastric cancer using conventional versus ALIs.

Methods: This retrospective study included 147 older patients (aged ≥70 years) who underwent laparoscopic distal gastrectomy for gastric cancer between 2017 and 2024. Surgery was performed using conventional laparoscopic instruments in 61 patients and ALIs in 86 patients. The median follow-up period was 20 months.

Results: Postoperative hospital stay was significantly shorter in the articulating group than in the conventional group (4.6 ± 2.0 days vs. 5.4 ± 2.4 days, P = 0.030). Time to first flatus was also significantly shorter in the articulating group (2.4 ± 0.7 days vs. 2.8 ± 1.0 days, P = 0.022). However, there were no significant differences in overall complications, major (≥grade III) complications (conventional, 1.2% vs. articulating, 0%; P = 0.398) overall survival, or recurrence-free survival between groups.

Conclusion: The use of articulating instruments in older adults undergoing laparoscopic distal gastrectomy for gastric cancer was associated with shorter postoperative hospital stays and faster recovery of bowel function, with no apparent detrimental effects on complications, recurrence, or survival. These findings suggest that ALIs enhance recovery and possibly overall surgical outcomes in this patient population.

目的:随着老年胃癌患者需要胃切除术的人数的增加,在这一弱势患者群体中使用提高手术安全性和减少术后并发症的技术变得越来越重要。铰接腹腔镜器械(ali)可以提高可操作性和精确性,为老年患者带来更好的结果。本研究的目的是比较老年人接受腹腔镜胃癌远端切除术的术后结果,采用传统的和非传统的。方法:本回顾性研究纳入147例2017 - 2024年间因胃癌行腹腔镜远端胃切除术的老年患者(年龄≥70岁)。61例患者采用常规腹腔镜手术,86例患者采用腹腔镜手术。中位随访期为20个月。结果:关节组术后住院时间明显短于常规组(4.6±2.0 d∶5.4±2.4 d, P = 0.030)。关节组首次放屁时间也明显缩短(2.4±0.7天vs. 2.8±1.0天,P = 0.022)。然而,总并发症、主要(≥III级)并发症(常规,1.2% vs.关节,0%;P = 0.398)总生存率,或组间无复发生存率。结论:老年人行腹腔镜胃癌远端胃切除术,使用关节器械可缩短术后住院时间,加快肠功能恢复,对并发症、复发或生存无明显不利影响。这些发现表明,在这类患者群体中,ali可以提高恢复,并可能提高整体手术效果。
{"title":"Enhanced recovery after laparoscopic distal gastrectomy using articulating laparoscopic instruments in older adults with gastric cancer: a retrospective analysis of prospectively collected data.","authors":"Seohee Choi, Takahiro Kinoshita, Kazutaka Obama, Katsunobu Sakurai, Naoshi Kubo, Naruhiko Ikoma, Ali Guner, Hyoung-Il Kim","doi":"10.4174/astr.2025.108.2.86","DOIUrl":"10.4174/astr.2025.108.2.86","url":null,"abstract":"<p><strong>Purpose: </strong>As the number of older adults with gastric cancer requiring gastrectomy has increased, it has become increasingly important to use techniques that enhance surgical safety and reduce postoperative complications in this vulnerable patient population. Articulating laparoscopic instruments (ALIs) may improve maneuverability and precision, leading to better outcomes in older patients. This study aimed to compare postoperative outcomes of older adults undergoing laparoscopic distal gastrectomy for gastric cancer using conventional versus ALIs.</p><p><strong>Methods: </strong>This retrospective study included 147 older patients (aged ≥70 years) who underwent laparoscopic distal gastrectomy for gastric cancer between 2017 and 2024. Surgery was performed using conventional laparoscopic instruments in 61 patients and ALIs in 86 patients. The median follow-up period was 20 months.</p><p><strong>Results: </strong>Postoperative hospital stay was significantly shorter in the articulating group than in the conventional group (4.6 ± 2.0 days <i>vs.</i> 5.4 ± 2.4 days, P = 0.030). Time to first flatus was also significantly shorter in the articulating group (2.4 ± 0.7 days <i>vs.</i> 2.8 ± 1.0 days, P = 0.022). However, there were no significant differences in overall complications, major (≥grade III) complications (conventional, 1.2% <i>vs.</i> articulating, 0%; P = 0.398) overall survival, or recurrence-free survival between groups.</p><p><strong>Conclusion: </strong>The use of articulating instruments in older adults undergoing laparoscopic distal gastrectomy for gastric cancer was associated with shorter postoperative hospital stays and faster recovery of bowel function, with no apparent detrimental effects on complications, recurrence, or survival. These findings suggest that ALIs enhance recovery and possibly overall surgical outcomes in this patient population.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"108 2","pages":"86-92"},"PeriodicalIF":1.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143405436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Surgical Treatment and Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1